BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11241055)

  • 1. Germline Wilms tumor suppressor gene (WT1) mutation leading to isolated genital malformation without Wilms tumor or nephropathy.
    Köhler B; Schumacher V; l'Allemand D; Royer-Pokora B; Grüters A
    J Pediatr; 2001 Mar; 138(3):421-4. PubMed ID: 11241055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes).
    Auber F; Lortat-Jacob S; Sarnacki S; Jaubert F; Salomon R; Thibaud E; Jeanpierre C; Nihoul-Fékété C
    J Pediatr Surg; 2003 Jan; 38(1):124-9; discussion 124-9. PubMed ID: 12592634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects.
    Köhler B; Pienkowski C; Audran F; Delsol M; Tauber M; Paris F; Sultan C; Lumbroso S
    Eur J Endocrinol; 2004 Jun; 150(6):825-30. PubMed ID: 15191353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusion of WTAP and HOXA13 as candidate genes for isolated hypospadias.
    Utsch B; Kaya A; Ozburun A; Lentze MJ; Albers N; Ludwig M
    Scand J Urol Nephrol; 2003; 37(6):498-501. PubMed ID: 14675924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.
    Terenziani M; Sardella M; Gamba B; Testi MA; Spreafico F; Ardissino G; Fedeli F; Fossati-Bellani F; Radice P; Perotti D
    Pediatr Nephrol; 2009 Jul; 24(7):1413-7. PubMed ID: 19048299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for mutations in candidate genes for hypospadias.
    Nordenskjöld A; Friedman E; Tapper-Persson M; Söderhäll C; Leviav A; Svensson J; Anvret M
    Urol Res; 1999; 27(1):49-55. PubMed ID: 10092153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
    Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
    Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of five candidate genes in Chinese patients with hypospadias.
    Wang Y; Li Q; Xu J; Liu Q; Wang W; Lin Y; Ma F; Chen T; Li S; Shen Y
    Eur J Hum Genet; 2004 Sep; 12(9):706-12. PubMed ID: 15266301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 nephropathy in a girl with normal karyotype (46,XX).
    Tsuda M; Owada M; Tsuchiya M; Murakami M; Sakiyama T
    Clin Nephrol; 1999 Jan; 51(1):62-3. PubMed ID: 9988151
    [No Abstract]   [Full Text] [Related]  

  • 17. Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
    Lugtenberg RT; Cransberg K; Loos WJ; Wagner A; Alders M; van den Heuvel-Eibrink MM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1039-44. PubMed ID: 18273617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].
    Wasilewska A; Zoch-Zwierz W; Tenderenda E; Rybi-Szumińska A; Kołodziejczyk Z
    Pol Merkur Lekarski; 2009 Jun; 26(156):642-4. PubMed ID: 19711733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
    Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
    Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.